Latest News & Features
Careers
The proposed 1,400-strong firm will combine Taylor Wessing's top UK and European practice with Winston & Strawn's US-focused IP litigation team. 15 December 2025
Europe
The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory hurdles, and talent shortages are raising questions about whether the target is achievable, finds Marisa Woutersen. 15 December 2025
Americas
Israeli drug maker bows to FTC pressure, removing scores of “improperly listed” patents in boon for generic manufacturers. 11 December 2025
Careers
The lateral hire from Covington & Burling will strengthen the firm's cross-border expertise as the UK and EU markets ‘navigate regulatory and technological shifts’, said the firm. 11 December 2025
Americas
In the complex world of bsAb patenting, counsel need to turn chefs to serve up success. Benjamin Pelletier of Haynes Boone puts together a menu of dos and don’ts. 10 December 2025
Asia
The Danish pharma giant is expanding its patent defence in India as multiple generics prepare to challenge its blockbuster diabetes and weight-loss drug ahead of 2026 patent expiry. 9 December 2025
Careers
New hires bring “exceptional technical expertise” and a strong track record across biotechnology and pharmaceutical patent matters. 9 December 2025
Americas
Solicitor General urges the US Supreme Court to hear an appeal in its dispute, arguing that a ruling threatens the future of skinny labelling and the availability of lower-cost generics. 9 December 2025
Europe
The firm has added a disputes specialist with experience in pharma, biotech and manufacturing sectors across multiple jurisdictions. 8 December 2025
Americas
As part of a broader bid to remove obstacles to patents, director Squires clarifies how examiners, applicants and practitioners may handle patent subject matter eligibility rejections. 8 December 2025